Characterization of the novel HLA‐B*40:495 and HLA‐B*40:512 alleles by next‐generation sequencing
HLA · 2023
DOI: 10.1111/tan.15012 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2023. Verfasst von Yizhen He und 4 weiteren Autor:innen. Beteiligte Einrichtung: HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China. Hauptthemen laut MEDLINE: HLA-B Antigens, Genes, MHC Class I. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 4 Literaturangaben.
Abstract (Originalsprache)
Compared with HLA‐B*40:01:02:01 , the alleles HLA‐B*40:495 and HLA‐B*40:512 each show one nucleotide substitution, respectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.
- HLA Typing Laboratory, Key Laboratory of Blood Safety Research of Zhejiang Province, Hangzhou, China.
ORCID-Profile: Faming Zhu
Zitieren
APA
He, Y., Chen, N., Dong, L., Zhang, W., & Zhu, F. (2023). Characterization of the novel HLA‐B*40:495 and HLA‐B*40:512 alleles by next‐generation sequencing. HLA. https://doi.org/10.1111/tan.15012
Vancouver
He Y, Chen N, Dong L, Zhang W, Zhu F. Characterization of the novel HLA‐B*40:495 and HLA‐B*40:512 alleles by next‐generation sequencing. HLA. 2023. doi:10.1111/tan.15012
BibTeX
@article{He2023,
author = {He, Yizhen and Chen, Nanying and Dong, Lina and Zhang, Wei and Zhu, Faming},
title = {Characterization of the novel HLA‐B*40:495 and HLA‐B*40:512 alleles by next‐generation sequencing},
journal = {HLA},
year = {2023},
doi = {10.1111/tan.15012}
}
EUVIMED